DNase I levels and disease outcome in JIA patients treated with etanercept

Ítems similars

• DNase I levels and disease outcome in JIA patients treated with etanercept
  per: Damjanov N, et al.
  Publicat: (2011-09-01)
• DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
  per: Vojinovic, J, et al.
  Publicat: (2008)
• Inflence of clinical and genetic characteristics on ability to achive and maintain remission in JIA patients on etanercept treatment
  per: Lazarevic, Dragana S, et al.
  Publicat: (2014)
• Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
  per: Vojinovic, J, et al.
  Publicat: (2011)
• Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
  per: Susic, G, et al.
  Publicat: (2008)